Amed Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Neurolutions develops IpsiHand, an FDA-cleared non-invasive brain-computer interface therapy for upper-extremity motor rehabilitation in chronic stroke survivors.
BiotechDeep TechDigital HealthHealthtechMedical DevicesVan Nuys, US
Eric Leuthardt(Founder (lab origin at Washington University in St. Louis))inLeo Petrossian(Chief Executive Officer & Director)inNabeel Ahmed(Chief Financial Officer)Kirsten Carroll(Chief Marketing Officer & General Manager, Service)Andy Schultz(Chief Commercial Officer)Javad Seyedzadeh(Chief Operations Officer)
Co-investorsBioGenerator VenturesExcelestar VenturesAlly Bridge Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


